Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 30 Carcinoma, Hepatocellular 13 Rectal Neoplasms 5 Sarcoma, Ewing 4 Osteosarcoma 4 Gastrointestinal Stromal Tumors 4 Colonic Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Glioblastoma 3 Sarcoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Bone Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Piebaldism 1 Patient Compliance 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Bevacizumab 7 Capecitabine 4 Cetuximab 3 trifluridine tipiracil drug combination 2 Fluorouracil 2 regorafenib 1 irinotecan sucrosofate 1 folfirinox 1 balstilimab 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Tomography, X-Ray Computed 1 Panitumumab 1 Nivolumab 1 Liver Transplantation 1 Immune Checkpoint Inhibitors 1 HMPL-013 1 Folfox protocol 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × regorafenib × 1 year × Clear all

NCT04874207 2025-08-08

RePERSO

Rennes University Hospital

Phase 4 Completed

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡